Where Will GlaxoSmithKline Be in 5 Years?
Over the past five years, GlaxoSmithKline's (NYSE: GSK) stock price has been on a roller coaster, but more down than up. As of Feb. 10, the stock price's five-year return is negative 2%, significantly underperforming both the healthcare technology and pharmaceutical sectors.
Compared to its peers, the U.K.-based company has not proven to be a great investment over that time span. But what about the next five years? Will investors who buy its stock today be rewarded in the future?
Source Fool.com
